228 related articles for article (PubMed ID: 22951831)
1. Epstein-Barr virus latent membrane protein 1 regulates the function of interferon regulatory factor 7 by inducing its sumoylation.
Bentz GL; Shackelford J; Pagano JS
J Virol; 2012 Nov; 86(22):12251-61. PubMed ID: 22951831
[TBL] [Abstract][Full Text] [Related]
2. LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.
Bentz GL; Moss CR; Whitehurst CB; Moody CA; Pagano JS
J Virol; 2015 Aug; 89(15):7465-77. PubMed ID: 25948750
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9.
Bentz GL; Whitehurst CB; Pagano JS
J Virol; 2011 Oct; 85(19):10144-53. PubMed ID: 21795333
[TBL] [Abstract][Full Text] [Related]
4. The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7.
Ning S; Pagano JS
J Virol; 2010 Jun; 84(12):6130-8. PubMed ID: 20392859
[TBL] [Abstract][Full Text] [Related]
5. Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit.
Ning S; Hahn AM; Huye LE; Pagano JS
J Virol; 2003 Sep; 77(17):9359-68. PubMed ID: 12915551
[TBL] [Abstract][Full Text] [Related]
6. The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-protease.
Selby TL; Biel N; Varn M; Patel S; Patel A; Hilding L; Ray A; Ross T; Cramblet WT; Moss CR; Lowrey AJ; Bentz GL
Sci Rep; 2019 Jul; 9(1):9523. PubMed ID: 31266997
[TBL] [Abstract][Full Text] [Related]
7. The Linear Ubiquitin Assembly Complex Modulates Latent Membrane Protein 1 Activation of NF-κB and Interferon Regulatory Factor 7.
Wang L; Wang Y; Zhao J; Ren J; Hall KH; Moorman JP; Yao ZQ; Ning S
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903798
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr Virus Latent Membrane Protein-1 Induces the Expression of SUMO-1 and SUMO-2/3 in LMP1-positive Lymphomas and Cells.
Salahuddin S; Fath EK; Biel N; Ray A; Moss CR; Patel A; Patel S; Hilding L; Varn M; Ross T; Cramblet WT; Lowrey A; Pagano JS; Shackelford J; Bentz GL
Sci Rep; 2019 Jan; 9(1):208. PubMed ID: 30659232
[TBL] [Abstract][Full Text] [Related]
9. Colocalization of interferon regulatory factor 7 (IRF7) with latent membrane protein 1 (LMP1) of Epstein-Barr virus.
Kim IW; Park HS
J Korean Med Sci; 2006 Jun; 21(3):379-84. PubMed ID: 16778376
[TBL] [Abstract][Full Text] [Related]
10. TRAF6 and the three C-terminal lysine sites on IRF7 are required for its ubiquitination-mediated activation by the tumor necrosis factor receptor family member latent membrane protein 1.
Ning S; Campos AD; Darnay BG; Bentz GL; Pagano JS
Mol Cell Biol; 2008 Oct; 28(20):6536-46. PubMed ID: 18710948
[TBL] [Abstract][Full Text] [Related]
11. Effects of targeting sumoylation processes during latent and induced Epstein-Barr virus infections using the small molecule inhibitor ML-792.
Garcia P; Harrod A; Jha S; Jenkins J; Barnhill A; Lee H; Thompson M; Williams JP; Barefield J; Mckinnon A; Suarez P; Shah A; Lowrey AJ; Bentz GL
Antiviral Res; 2021 Apr; 188():105038. PubMed ID: 33577806
[TBL] [Abstract][Full Text] [Related]
12. Interferon regulatory factor 5 represses expression of the Epstein-Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuit.
Ning S; Huye LE; Pagano JS
J Virol; 2005 Sep; 79(18):11671-6. PubMed ID: 16140744
[TBL] [Abstract][Full Text] [Related]
13. IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3.
Song YJ; Izumi KM; Shinners NP; Gewurz BE; Kieff E
Proc Natl Acad Sci U S A; 2008 Nov; 105(47):18448-53. PubMed ID: 19017798
[TBL] [Abstract][Full Text] [Related]
14. Interferon regulatory factor 7 is activated by a viral oncoprotein through RIP-dependent ubiquitination.
Huye LE; Ning S; Kelliher M; Pagano JS
Mol Cell Biol; 2007 Apr; 27(8):2910-8. PubMed ID: 17296724
[TBL] [Abstract][Full Text] [Related]
15. IRF7: activation, regulation, modification and function.
Ning S; Pagano JS; Barber GN
Genes Immun; 2011 Sep; 12(6):399-414. PubMed ID: 21490621
[TBL] [Abstract][Full Text] [Related]
16. TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.
Greenfeld H; Takasaki K; Walsh MJ; Ersing I; Bernhardt K; Ma Y; Fu B; Ashbaugh CW; Cabo J; Mollo SB; Zhou H; Li S; Gewurz BE
PLoS Pathog; 2015 May; 11(5):e1004890. PubMed ID: 25996949
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3.
Kung CP; Raab-Traub N
J Virol; 2008 Jun; 82(11):5486-93. PubMed ID: 18367518
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr Virus Oncoprotein LMP1 Mediates Epigenetic Changes in Host Gene Expression through PARP1.
Martin KA; Lupey LN; Tempera I
J Virol; 2016 Oct; 90(19):8520-30. PubMed ID: 27440880
[TBL] [Abstract][Full Text] [Related]
19. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
20. Canonical NF-kappaB activation is essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene regulation.
Gewurz BE; Mar JC; Padi M; Zhao B; Shinners NP; Takasaki K; Bedoya E; Zou JY; Cahir-McFarland E; Quackenbush J; Kieff E
J Virol; 2011 Jul; 85(13):6764-73. PubMed ID: 21543491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
